Skip to search formSkip to main contentSkip to account menu

valsartan

Known as: N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine, (S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine, N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine 
An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and… 
National Institutes of Health

Related topics

Related topics

39 relations
Amlodipine / valsartanAmlodipine 10 MG / Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet [Exforge HCT]Amlodipine 5 MG / Hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet [Exforge HCT]Angiotensin 2 Receptor Antagonists [MoA]

Broader (2)

Angiotensin II Type 1 Receptor BlockersAntihypertensive Agents

Narrower (10)

ByvalsonCGP 48933DiovanEntresto

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Preparation and in vitro & in vivo characterization of valsartan loaded eudragit nanoparticles
The aim of the present work was to prepare and inve stigate the valsartan nanoparticles. nanoparticles were prepared by… 
2012
2012
FORMULATION AND EVALUATION OF SUSTAINED RELEASE VALSARTAN MATRIX TABLETS BY USING NATURAL POLYMERS
The present study was aimed to develop antihypertensive sustained release matrix tables of valsartan Angiotensin II receptor… 
2012
2012
TABLET FORMULATION AND DEVELOPMENT OF A VALIDATED STABILITY INDICATING HPLC METHOD FOR QUANTIFICATION OF VALSARTAN AND HYDROCHLORTHIAZIDE COMBINATION Research Article
This study was aimed to develop valsartan/ hydrochlorothiazide tablet formulation and to develop a stability indicating HPLC… 
2011
2011
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
The effect of antihypertensive drugs on lipoprotein subfraction profile is still under investigation. In this study the effects… 
2010
2010
Role of renin-angiotensin system blockades in reciprocal relationship between insulin resistance and endothelial dysfunction.
To the Editor: Azekoshi et al1 demonstrated that the enhanced production of angiotensin II by free fatty acid in mononuclear and… 
2010
2010
Formulation and evaluation of Valsartan film coated tablets
Valsartan used for the treatment of Hypertension, which is a specific angiotensin II receptor blocker (ARB) acting on the AT1… 
2009
2009
Simultaneous Determination of Valsartan and Nebivolol HCl in Tablet Dosage Form by RP-HPLC
A simple, fast and precise reversed phase high performance liquid chromatographic method is developed for the simultaneous… 
Review
2001
Review
2001
Valsartan and the kidney: Review of preclinical and clinical data
In both diabetic and nondiabetic renal disease, reducing blood pressure with antihypertensive therapy has beneficial effects on… 
2001
2001
Neutral effect of valsartan on serum uric acid and renal function tests
Despite extensive research it is still debatable whether uric acid is an independent cardiovascular risk factor or merely a… 
1999
1999
Valsartan/hydrochlorothiazide. Commentaries
Valsartan/hydrochlorothiazide (HCTZ) combines an angiotensin II AT 1 receptor blocker with a thiazide diuretic to produce…